Biotech

All Articles

Kairos goes social along with $6M IPO to money trials of cancer cells medication

.With a triad of biotechs striking the Nasdaq on Friday, it was simple to skip a smaller-scale publi...

Vaccine and Keytruda combination helpful in squamous tissue carcinoma

.Immune system gate inhibitors are actually the superheroes of cancer cells therapy. Medicines like ...

Cue Biopharma mark time J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of significant management hirings, firings as...

Regeneron's Opdualag competitor shows 57% action cost

.Regeneron is actually back along with long-term follow-up for its own LAG-3 prevention as well as P...

AstraZeneca articles records on internal rivals to AbbVie, Pfizer ADCs

.AstraZeneca has discussed an early look at the performance of its in-house antibody-drug conjugate ...

iTeos- GSK's TIGIT star shows relevant remodeling

.After revealing a period 3 launch based on good midstage end results, iTeos and also GSK are actual...

More collective FDA may increase unusual disease R&ampD: file

.The FDA needs to be actually more available as well as collective to discharge a surge in approvals...

Zenas, MBX, Bicara head to Nasdaq in warm day for biotech IPOs

.It's an unusually active Friday for biotech IPOs, with Zenas BioPharma, MBX and Bicara Rehabs all g...

Atea's COVID antiviral fails to halt hospitalizations in period 3

.Atea Pharmaceuticals' antiviral has failed another COVID-19 trial, however the biotech still holds ...

Neurocrine's quote to save schizophrenia possibility neglects

.Neurocrine Biosciences' schizophrenia program pivot has stopped working. The biotech was unable to ...